| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |